CD Streptomycin Rapid Test is a competitive immunoassay for the semi-quantitative detection of the presence of Streptomycin residue in aquatic product sample.
The first aminoglycoside was streptomycin, which was created from the fungus like bacterium Streptomyces griseus. Streptomycin's ototoxic potential was recognized quite early. In response, researchers modified the drug's molecule and created dihydrostreptomycin. Unlike its predecessor, dihydrostreptomycin is much more cochleotoxic than it is vestibulotoxic; in fact, it is almost exactly as cochleotoxic as streptomycin is vestibulotoxic. Later, investigators tried to reduce the risk of both toxicities by combining equal amounts of the two drugs, but this only resulted in patients experiencing both toxicities rather than neither.
Principle Of The Test
CD Streptomycin Rapid Test is based on competitive lateral flow immunochromatographic assay. The Streptomycin conjugate in the test zone will capture the immuno-gold (colloid gold-Streptomycin antibody conjugate), when there is very little dissociative Streptomycin in the samples. A visible red test band indicates a negative result when the control line (C zone) shows that the card is valid. The test band (T zone) will be not visible if Streptomycin is present in concentration of 100 ppb and above which explains a positive result.